[The therapeutic effect of nitromint retard on patients with stable angina pectoris]. 1990

Kh Tsekov, and D Karastatev, and D Mazhdrakova, and Zh Georgieva, and Ia Ginkova, and B Todorov, and R Dermendzhieva, and B Rangochev

The antianginal [correction of antidiagnose] efficacy of nitromint retard was studied in 62 middle aged patients with angina pectoris in a 4 week treatment with a 24 h dose of 2.6 mg. Bicycle ergometry [correction of A veloergometria] was conducted before the treatment and at the end of the fourth week. The average number of anginal attacks decreased from 4.0 +/- 1.9 to 1.6 +/- 1.3 during the first week and to 0.0 +/- 0.7 at the end of the 3rd week. The average threshold power increased at the end of the 4th week. Nitromint retard increased considerably the tolerance to physical load and did not increase the consumption of oxygen. The desired effect was achieved in 66.13% of the patients.

UI MeSH Term Description Entries
D010807 Physical Endurance The time span between the beginning of physical activity by an individual and the termination because of exhaustion. Endurance, Physical,Physical Stamina,Stamina, Physical
D003692 Delayed-Action Preparations Dosage forms of a drug that act over a period of time by controlled-release processes or technology. Controlled Release Formulation,Controlled-Release Formulation,Controlled-Release Preparation,Delayed-Action Preparation,Depot Preparation,Depot Preparations,Extended Release Formulation,Extended Release Preparation,Prolonged-Action Preparation,Prolonged-Action Preparations,Sustained Release Formulation,Sustained-Release Preparation,Sustained-Release Preparations,Timed-Release Preparation,Timed-Release Preparations,Controlled-Release Formulations,Controlled-Release Preparations,Extended Release Formulations,Extended Release Preparations,Slow Release Formulation,Sustained Release Formulations,Controlled Release Formulations,Controlled Release Preparation,Controlled Release Preparations,Delayed Action Preparation,Delayed Action Preparations,Formulation, Controlled Release,Formulations, Controlled Release,Prolonged Action Preparation,Release Formulation, Controlled,Release Formulations, Controlled,Sustained Release Preparation,Timed Release Preparation,Timed Release Preparations
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005080 Exercise Test Controlled physical activity which is performed in order to allow assessment of physiological functions, particularly cardiovascular and pulmonary, but also aerobic capacity. Maximal (most intense) exercise is usually required but submaximal exercise is also used. Arm Ergometry Test,Bicycle Ergometry Test,Cardiopulmonary Exercise Testing,Exercise Testing,Step Test,Stress Test,Treadmill Test,Cardiopulmonary Exercise Test,EuroFit Tests,Eurofit Test Battery,European Fitness Testing Battery,Fitness Testing,Physical Fitness Testing,Arm Ergometry Tests,Bicycle Ergometry Tests,Cardiopulmonary Exercise Tests,Ergometry Test, Arm,Ergometry Test, Bicycle,Ergometry Tests, Arm,Ergometry Tests, Bicycle,EuroFit Test,Eurofit Test Batteries,Exercise Test, Cardiopulmonary,Exercise Testing, Cardiopulmonary,Exercise Tests,Exercise Tests, Cardiopulmonary,Fitness Testing, Physical,Fitness Testings,Step Tests,Stress Tests,Test Battery, Eurofit,Test, Arm Ergometry,Test, Bicycle Ergometry,Test, Cardiopulmonary Exercise,Test, EuroFit,Test, Exercise,Test, Step,Test, Stress,Test, Treadmill,Testing, Cardiopulmonary Exercise,Testing, Exercise,Testing, Fitness,Testing, Physical Fitness,Tests, Arm Ergometry,Tests, Bicycle Ergometry,Tests, Cardiopulmonary Exercise,Tests, EuroFit,Tests, Exercise,Tests, Step,Tests, Stress,Tests, Treadmill,Treadmill Tests
D005996 Nitroglycerin A volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium. It is also sometimes used for TOCOLYSIS and explosives. Glyceryl Trinitrate,Anginine,Dynamite,Gilustenon,Nitrangin,Nitro-Bid,Nitro-Dur,Nitrocard,Nitroderm,Nitroderm TTS,Nitroglyn,Nitrol,Nitrolan,Nitrong,Nitrospan,Nitrostat,Perlinganit,Susadrin,Sustac,Sustak,Sustonit,Transderm Nitro,Tridil,Trinitrin,Trinitrolong,Nitro Bid,Nitro Dur,NitroBid,NitroDur,Trinitrate, Glyceryl
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000787 Angina Pectoris The symptom of paroxysmal pain consequent to MYOCARDIAL ISCHEMIA usually of distinctive character, location and radiation. It is thought to be provoked by a transient stressful situation during which the oxygen requirements of the MYOCARDIUM exceed that supplied by the CORONARY CIRCULATION. Angor Pectoris,Stenocardia,Stenocardias
D013607 Tablets Solid dosage forms, of varying weight, size, and shape, which may be molded or compressed, and which contain a medicinal substance in pure or diluted form. (Dorland, 28th ed) Tablet
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

Kh Tsekov, and D Karastatev, and D Mazhdrakova, and Zh Georgieva, and Ia Ginkova, and B Todorov, and R Dermendzhieva, and B Rangochev
January 1987, Therapia Hungarica (English edition),
Kh Tsekov, and D Karastatev, and D Mazhdrakova, and Zh Georgieva, and Ia Ginkova, and B Todorov, and R Dermendzhieva, and B Rangochev
October 1992, Zeitschrift fur Kardiologie,
Kh Tsekov, and D Karastatev, and D Mazhdrakova, and Zh Georgieva, and Ia Ginkova, and B Todorov, and R Dermendzhieva, and B Rangochev
January 2000, Klinicheskaia meditsina,
Kh Tsekov, and D Karastatev, and D Mazhdrakova, and Zh Georgieva, and Ia Ginkova, and B Todorov, and R Dermendzhieva, and B Rangochev
January 1977, Kardiologia polska,
Kh Tsekov, and D Karastatev, and D Mazhdrakova, and Zh Georgieva, and Ia Ginkova, and B Todorov, and R Dermendzhieva, and B Rangochev
September 1993, Vnitrni lekarstvi,
Kh Tsekov, and D Karastatev, and D Mazhdrakova, and Zh Georgieva, and Ia Ginkova, and B Todorov, and R Dermendzhieva, and B Rangochev
September 2007, Nihon rinsho. Japanese journal of clinical medicine,
Kh Tsekov, and D Karastatev, and D Mazhdrakova, and Zh Georgieva, and Ia Ginkova, and B Todorov, and R Dermendzhieva, and B Rangochev
January 2002, Klinicheskaia meditsina,
Kh Tsekov, and D Karastatev, and D Mazhdrakova, and Zh Georgieva, and Ia Ginkova, and B Todorov, and R Dermendzhieva, and B Rangochev
May 1990, Ugeskrift for laeger,
Kh Tsekov, and D Karastatev, and D Mazhdrakova, and Zh Georgieva, and Ia Ginkova, and B Todorov, and R Dermendzhieva, and B Rangochev
March 1979, Minerva cardioangiologica,
Kh Tsekov, and D Karastatev, and D Mazhdrakova, and Zh Georgieva, and Ia Ginkova, and B Todorov, and R Dermendzhieva, and B Rangochev
December 1989, Vnitrni lekarstvi,
Copied contents to your clipboard!